The acquisition includes five key growth brands Kelo-cote™, Flammacerium™, Aloclair™, Kelo-stretch™, and Atopiclair™. The move will strengthen Alliance's dermatology portfolio and significantly increase its footprint outside of the UK and provide an enhanced platform for further corporate development.
Cambridge-based patent and trade mark firm Mewburn Ellis LLP continues to assist Alliance with their intellectual property portfolio.